{"id":"https://openalex.org/W3106937503","doi":null,"title":"The legacy of MeNZB and possible implications for COVID-19 vaccination.","display_name":"The legacy of MeNZB and possible implications for COVID-19 vaccination.","alternate_titles":[],"publication_year":2020,"publication_date":"2020-11-20","ids":{"openalex":"https://openalex.org/W3106937503","mag":"3106937503","pmid":"https://pubmed.ncbi.nlm.nih.gov/33223554"},"language":"en","primary_location":{"id":"pmid:33223554","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33223554","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New Zealand medical journal","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W3106937503"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103938531","display_name":"James Stewart Reid","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"James Stewart Reid","raw_affiliation_strings":["Retired, Waikanae"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retired, Waikanae","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5103938531"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"133","issue":"1525","first_page":"114","last_page":"118"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":0.8730000257492065,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":0.8730000257492065,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.08320000022649765,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10833","display_name":"Vaccine Coverage and Hesitancy","score":0.0210999995470047,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serogroup-b-meningococcal-vaccine","display_name":"meningococcal B vaccine","score":0.9380000233650208},{"id":"https://openalex.org/keywords/vaccine-safety-surveillance","display_name":"vaccine safety surveillance","score":0.8569999933242798},{"id":"https://openalex.org/keywords/covid-19-vaccines","display_name":"COVID-19 vaccines","score":0.8180000185966492},{"id":"https://openalex.org/keywords/vaccine-cost","display_name":"vaccine cost","score":0.4359999895095825},{"id":"https://openalex.org/keywords/meningococcal-disease-incidence","display_name":"meningococcal disease incidence","score":0.6869999766349792},{"id":"https://openalex.org/keywords/new-zealand","display_name":"New Zealand","score":0.7730000019073486}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.914827823638916},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.7794837951660156},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.6321063041687012},{"id":"https://openalex.org/C2780454893","wikidata":"https://www.wikidata.org/wiki/Q6817090","display_name":"Meningococcal vaccine","level":4,"score":0.5943801999092102},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5372097492218018},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.517874002456665},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.5149827599525452},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.4605748653411865},{"id":"https://openalex.org/C2776645655","wikidata":"https://www.wikidata.org/wiki/Q890785","display_name":"Meningococcal disease","level":4,"score":0.44624394178390503},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.43621838092803955},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.31880608201026917},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.2950829267501831},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2423097789287567},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.23830324411392212},{"id":"https://openalex.org/C2778458888","wikidata":"https://www.wikidata.org/wiki/Q154625","display_name":"Neisseria meningitidis","level":3,"score":0.19648385047912598},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.10380077362060547},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.079810231924057},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006285","descriptor_name":"Health Planning","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008589","descriptor_name":"Meningococcal Infections","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D008589","descriptor_name":"Meningococcal Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D009520","descriptor_name":"New Zealand","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D012042","descriptor_name":"Registries","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D017589","descriptor_name":"Immunization Programs","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D017589","descriptor_name":"Immunization Programs","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D017589","descriptor_name":"Immunization Programs","qualifier_ui":"Q000458","qualifier_name":"organization & administration","is_major_topic":true},{"descriptor_ui":"D017751","descriptor_name":"Safety Management","qualifier_ui":"Q000458","qualifier_name":"organization & administration","is_major_topic":false},{"descriptor_ui":"D020380","descriptor_name":"Needs Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D022401","descriptor_name":"Meningococcal Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D022401","descriptor_name":"Meningococcal Vaccines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D038541","descriptor_name":"Neisseria meningitidis, Serogroup B","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D058436","descriptor_name":"Knowledge Management","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062665","descriptor_name":"Epidemiological Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:33223554","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33223554","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New Zealand medical journal","raw_type":"Journal Article"},{"id":"mag:3106937503","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33223554/","pdf_url":null,"source":{"id":"https://openalex.org/S5406947111","display_name":"New Zealand Medical Journal","issn_l":"2423-0588","issn":["2423-0588","0028-8446","1175-8716"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-d","doyens","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"New Zealand medical journal","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2431292926","https://openalex.org/W1538468828","https://openalex.org/W1576152613","https://openalex.org/W2106420760","https://openalex.org/W2022965285","https://openalex.org/W2067332669","https://openalex.org/W1977867564","https://openalex.org/W43534825","https://openalex.org/W2092594449","https://openalex.org/W7011398980"],"abstract_inverted_index":{"It":[0],"is":[1,102,145],"now":[2],"over":[3,33],"a":[4,29,34,75,83,96,142,148],"decade":[5],"since":[6],"the":[7,47,57,60,63,93,111,114],"meningococcal":[8,79],"B":[9,52],"vaccine,":[10],"MeNZB,":[11],"was":[12,26,65],"in":[13,16,28,67,85,104],"routine":[14],"use":[15],"New":[17],"Zealand.":[18],"From":[19],"July":[20],"2004":[21],"until":[22],"June":[23],"2008":[24],"it":[25,72],"administered":[27],"three-dose":[30],"schedule":[31],"to":[32,40,43,74,92,126],"million":[35],"individuals,":[36],"aged":[37],"six":[38],"weeks":[39],"20":[41],"years,":[42],"provide":[44],"protection":[45],"against":[46],"epidemic":[48],"strain":[49],"of":[50,56,62,69,78,95,113],"group":[51],"Meningococci.":[53],"The":[54,89],"cost":[55],"campaign,":[58],"including":[59],"development":[61,94],"vaccine":[64,132,144],"substantial,":[66],"excess":[68],"$200M,":[70],"but":[71],"contributed":[73],"reduced":[76],"incidence":[77],"infections":[80],"along":[81],"with":[82],"reduction":[84],"morbidity":[86],"and":[87,140,147],"mortality.":[88],"campaign":[90,151],"led":[91],"national":[97,149],"immunisation":[98,150],"register":[99],"(NIR),":[100],"which":[101,135],"still":[103],"existence":[105],"today.":[106],"As":[107],"well":[108],"as":[109],"considering":[110],"legacies":[112],"MeNZB":[115],"vaccination":[116],"programme,":[117],"this":[118],"paper":[119],"examines":[120],"whether":[121],"there":[122],"are":[123],"any":[124],"lessons":[125],"be":[127,137],"learned,":[128],"specifically":[129],"concerning":[130],"active":[131],"safety":[133],"monitoring,":[134],"may":[136],"important":[138],"if,":[139],"when,":[141],"COVID-19":[143],"developed":[146],"instituted.":[152]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3106937503","counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2020-12-07T00:00:00"}
